worldwide pandemic – Page 21 – Communicable Diseases Research

Spectrum of neuroimaging findings in COVID-19

Pictorial Review

Published on 2021-01-012022-10-27
Journal: The British Journal of Radiology [Category] COVID-19, MERS,

Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19

과염증 COVID-19에서 백혈구에 의한 순환 사이토카인과 자발적 사이토카인 생산 간의 불일치

Clinical Trial

Published on 2021-01-012022-09-12
Journal: Journal of leukocyte biology [Category] MERS, 임상, 진단,

[키워드] activated Activation analyzed blockade cellular circulating cytokine circulating leukocyte contribute Control controls COVID-19 COVID-19 patient COVID-19 patients cytokine cytokine production Cytokine storm cytokine storm, monocytes. Cytokines disease example flow cytometry healthy control healthy controls hyperinflammation Hyperinflammatory IL-1β IL-6 IL-8 immunoassay investigated leukocyte LPS lymphocyte mismatch monocyte Monocytes Patient patients with COVID-19 PBMC produced recruited Sepsis sepsis patient sepsis patients severe COVID-19 Support surface marker TNF Treatment university was used were measured worldwide pandemic
[DOI] 10.1002/JLB.5COVBCR0720-310RR PMC 바로가기 [Article Type] Clinical Trial

Spectrum of neuroimaging findings in COVID-19

COVID-19의 신경 영상 소견 스펙트럼

Pictorial Review

Published on 2021-01-012022-09-12
Journal: The British Journal of Radiology [Category] 진단,

Mutational spectra of SARS-CoV-2 isolated from animals

Microbiology

Published on 2020-12-182022-10-28
Journal: PeerJ [Category] COVID-19,

Identification and Validation of a Novel Clinical Signature to Predict the Prognosis in Confirmed Coronavirus Disease 2019 Patients

Randomized Controlled Trial

Published on 2020-12-152022-10-05
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상,

[키워드] Accuracy age Analysis both group C-reactive protein caused characteristic clinical Confirmed coronavirus coronavirus disease COVID-19 COVID-19 patient Critically ill demonstrated disease group groups highest identification identify indicated log-rank test Lymphocyte count mortality rate multivariate Cox regression neutrophil count novel Patient performed predict prediction Predictive Probability procalcitonin Prognosis prognostic biomarker randomly divided reduce risk risk model ROC ROC analysis signature significantly stratified surpassed survival the disease Treatment validation was selected worldwide pandemic
[DOI] 10.1093/cid/ciaa793 PMC 바로가기 [Article Type] Randomized Controlled Trial

High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study

고용량 콜레칼시페롤 부스터 요법은 COVID-19 환자의 사망률 감소와 관련이 있습니다: 횡단면 다중 센터 관찰 연구

Clinical Trial

Published on 2020-12-112022-08-13
Journal: Nutrients [Category] MERS, SARS, 임상,

[키워드] 2019 novel coronavirus 2019 novel coronavirus disease 25-hydroxyvitamin D 95% CI affected appear baseline carried cholecalciferol cholecalciferol booster therapy cholecalciferol therapy clinical trial Cohort collected confounder coronavirus disease COVID-19 COVID-19 mortality determine disease Efficacy hospitalised in-patient Logistic regression Mortality Novel coronavirus novel coronavirus 2019 novel coronavirus disease observational study participant Patient patients pharmacological management population studies predictor predictors public health recruited reduced risk replicated SARS-CoV-2 serum serum 25-hydroxyvitamin D therapeutic option therapeutic options Treatment UK hospitals validation cohort Vitamin D Vitamin D status vitamin D treatment was used with COVID-19 worldwide pandemic
[DOI] 10.3390/nu12123799 PMC 바로가기 [Article Type] Clinical Trial

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Clinical Trial

Published on 2020-12-102022-10-04
Journal: The New England Journal of Medicine [Category] MERS, SARS, 임상,

[키워드] 1:1 acute respiratory syndrome age assigned baseline BNT162b2 BNT162b2 mRNA BNT162b2 vaccine body-mass characterized conditions coronavirus coronavirus disease defined dose doses effective effective vaccine Efficacy ENCODE fatigue first dose full-length spike protein groups headache incidence Infection injection laboratory-confirmed median Mild-to-moderate nucleoside-modified RNA observer-blinded occurred of BNT162b2 Older Pain participant Placebo placebo recipient placebo-controlled prefusion primary end point randomization Randomly receive Result resulting Safety safety profile SARS-CoV-2 second dose Serious Adverse Event Sex subgroup the vaccine Trial two-dose regimen Vaccine Vaccines worldwide pandemic
[DOI] 10.1056/NEJMoa2034577 PMC 바로가기 [Article Type] Clinical Trial

Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications

Cell and Developmental Biology

Published on 2020-12-102022-10-31
Journal: Frontiers in Cell and Developmental Biology [Category] COVID-19,

Telemedicine in Heart Failure During COVID-19: A Step Into the Future

Cardiovascular Medicine

Published on 2020-12-092022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

Early prediction and identification for severe patients during the pandemic of COVID-19: A severe COVID-19 risk model constructed by multivariate logistic regression analysis

Research Theme 1: COVID-19 Pandemic

Published on 2020-12-042022-10-31
Journal: Journal of Global Health [Category] COVID-19, MERS, SARS,

[키워드] age albumin Analysis caused Clinical characteristics Clinical data clinician Comorbidities Corona COVID-19 demonstrated duration of fever early stage elevated enrolled evaluate Factor force help hypertension identify illness onset independent Infectious disease Lymphocyte count lymphopenia mechanical ventilation Mild Mortality Most patient multivariate logistic regression Negative predictive value neutrophil lymphocyte ratio NLR oxygen pandemic Patient patients with COVID-19 Positive predictive value Predictive predictor proportion receiver operating characteristic reducing required respiratory symptoms Result retrospective risk ROC ROC Curve second Sensitivity and specificity severe COVID-19 severe group Severe patient severe patients therapeutic Treatment two groups university viral clearance was used were used worldwide pandemic
[DOI] 10.7189/jogh.10.020510 PMC 바로가기 [Article Type] Research Theme 1: COVID-19 Pandemic